Hemangiogenesis and lymphangiogenesis in corneal pathology

Cornea

Volumn 31, Issue 1, 2012, Pages 74-80

  Tshionyi, Makambo ^a   Shay, Elizabeth ^a   Lunde, Elisa ^a   Lin, Amy ^b   Han, Kyu Yeon ^a   Jain, Sandeep ^a   Chang, Jin Hong ^a   Azar, Dimitri T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CD31; Corneal neovascularization; Hemangiogenesis; Lymphangiogenesis; LYVE 1

Indexed keywords

CD31 ANTIGEN; LYMPHATIC VESSEL ENDOTHELIAL HA RECEPTOR 1 PROTEIN, HUMAN; LYMPHATIC VESSEL ENDOTHELIAL HA RECEPTOR-1 PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ARTICLE; CORNEA; CORNEA NEOVASCULARIZATION; CORNEA STROMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; METABOLISM; PATHOLOGY; VASCULARIZATION;

ANTIGENS, CD31; CORNEA; CORNEAL NEOVASCULARIZATION; CORNEAL STROMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; VESICULAR TRANSPORT PROTEINS;

EID: 84856453639     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31821dd986     Document Type: Article

References (42)

1. Cursiefen C, Maruyama K, Jackson DG, et al. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea. 2006;25:443-447.
2. Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:264-302.
3. Regenfuss B, Bock F, Parthasarathy A, et al. Corneal (lymph) angiogenesis-from bedside to bench and back: a tribute to Judah Folkman. Lymphat Res Biol. 2008;6:191-201.
4. Chang JH, Gabison EE, Kato T, et al. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242-249.
5. Ellenberg D, Azar DT, Hallak JA, et al. Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res. 2010;29:208-248.
6. Gong Y, Koh DR. Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res. 2010;339:437-448.
7. Chung ES, Chauhan SK, Jin Y, et al. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol. 2009;175:1984-1992.
8. Regina M, Zimmerman R, Malik G, et al. Lymphangiogenesis concurrent with haemangiogenesis in the human cornea. Clin Experiment Ophthalmol. 2007;35:541-544.
9. Onguchi T, Han KY, Chang JH, et al. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am J Pathol. 2009;174:1564-1571.
10. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008;99:1501-1506.
11. Ebrahem Q, Minamoto A, Hoppe G, et al. Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors. Invest Ophthalmol Vis Sci. 2006;47:4935-4941.
12. Bourcier T, Berbar T, Paquet S, et al. Characterization and functionality of CXCR4 chemokine receptor and SDF-1 in human corneal fibroblasts. Mol Vis. 2003;9:96-102.
13. Zhang J, Cao R, Zhang Y, et al. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. F A S E B J. 2009;23:153-163.
14. Ecoiffier T, Yuen D, Chen L. Differential distribution of blood and lymphatic vessels in the murine cornea. Invest Ophthalmol Vis Sci. 2010;51:2436-2440.
15. Shi W, Liu J, Li M, et al. Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors. Curr Eye Res. 2010;35:967-977.
16. Wuest TR, Carr DJ. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med. 2010;207:101-115.
17. Conrad TJ, Chandler DB, Corless JM, et al. In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis. Lab Invest. 1994;70:426-434.
18. Qazi Y, Maddula S, Ambati BK. Mediators of ocular angiogenesis. J Genet. 2009;88:495-515.
19. Ben Ezra D, Griffin BW, Maftzir G, et al. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci. 1997;38:1954-1962.
20. Gordon YJ, Mann RK, Mah TS, et al. Fluorescein-potentiated argon laser therapy improves symptoms and appearance of corneal neovascularization. Cornea. 2002;21:770-773.
21. Inoue K, Amano S, Oshika T, et al. Risk factors for corneal graft failure and rejection in penetrating keratoplasty. Acta Ophthalmol Scand. 2001;79:251-255.
22. Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidencebased meta-analysis. Ophthalmology. 2010;117:1300-1305 e1307.
23. Vassileva PI, Hergeldzhieva TG. Avastin use in high risk corneal transplantation. Graefes Arch Clin Exp Ophthalmol. 2009;247:1701-1706.
24. Chung ES, Saban DR, Chauhan SK, et al. Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci. 2009;50:1613-1618.
25. Cho WG, Albuquerque RJ, Kleinman ME, et al. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci U S A. 2009;106:7137-7142.
26. Dana MR. Angiogenesis and lymphangiogenesis-implications for corneal immunity. Semin Ophthalmol. 2006;21:19-22.
27. Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N YAcad Sci. 2008;1131:1-12.
28. Jackson DG. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev. 2009;230:216-231.
29. Jackson DG, Prevo R, Clasper S, et al. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 2001;22:317-321.
30. Niederkorn JY. Immune mechanisms of corneal allograft rejection. Curr Eye Res. 2007;32:1005-1016.
31. Cosar CB, Sridhar MS, Sener B. Late onset of deep corneal vascularization: a rare complication of intrastromal corneal ring segments for keratoconus. Eur J Ophthalmol. 2009;19:298-300.
32. Madigan MC, Penfold PL, Holden BA, et al. Ultrastructural features of contact lens-induced deep corneal neovascularization and associated stromal leukocytes. Cornea. 1990;9:144-151.
33. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115:2363-2372.
34. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45:2666-2673.
35. Ling S, Lin H, Xiang D, et al. Clinical and experimental research of corneal lymphangiogenesis after keratoplasty. Ophthalmologica. 2008;222:308-316.
36. Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci. 2002;43:2127-2135.
37. Watari K, Nakao S, Fotovati A, et al. Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun. 2008;377:826-831.
38. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245-269.
39. Espana EM, Di Pascuale MA, He H, et al. Characterization of corneal pannus removed from patients with total limbal stem cell deficiency. Invest Ophthalmol Vis Sci. 2004;45:2961-2966.
40. Naib-Majani W, Breipohl W, Shazli EE, et al. The Ets-1 transcription factor is involved in pterygial angiogenesis. Anat Histol Embryol. 2007;36:107-110.
41. Saravia M, Zapata G, Ferraiolo P, et al. Anti-VEGF monoclonal antibodyinduced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol. 2009;247:1409-1416.
42. Cursiefen C, Kuchle M, Naumann GO. Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization. Cornea. 1998;17:611-613.